News

Introducing Illumina Ampliseq On-demand custom panels

Create amplicon panels with the genes you want. AmpliSeq for Illumina On Demand panels provide a choice of > 5000 pretested genes with known content relevant for inherited disease research, including hereditary cancer, primary immunodeficiency, hearing loss, and muscular dystrophy. AmpliSeq chemistry and Illumina next-generation sequencing (NGS) technology provide unmatched data quality, even from low-quality…
Читать далее

Illumina Day, May 15-16, Kyiv, UNIT City

Illumina day in Kyiv is an event focused on next generation sequencing with the emphasis on its use for diagnostic and basic research purpose in medicine and biology, llumina Day will take place at UNIT.City on May 15-16. Our keynote speaker, Prof. Rafał Płoski (Poland), as well Illumina's Ukrainian customers will share their NGS experience and success…
Читать далее

Illumina passed its forensic portfolio to Verogen

Starting of 2018,  products and solutions for forensic genetics and human identification will be supplied by Verogen. This company has taken over all the relevant Illumina portfolio based on NGS using the MiSeq FGx system,  ForenSeq DNA Signature Prep Kit, and ForenSeq Universal Analysis Software program, for genomic DNA sampling. At the same time, for the…
Читать далее

Introducing AmpliSeq™ for Illumina®

AmpliSeq for Illumina is a suite of AmpliSeq chemistry products that are compatible with Illumina next-generation sequencing platforms. The AmpliSeq for Illumina solution offers a highly multiplexed polymerase chain reaction (PCR)-based workflow for use with targets ranging from a few to hundreds in a single run. Combined with Illumina next-generation sequencing (NGS) technology, AmpliSeq for…
Читать далее

IMG is now an official distributor of Illumina Inc. in Ukraine

In march 2017 IMG became an official representer and distributor of Illumina on the Ukrainian market. We offer our service and technical support in the acquisition and operation of Illumina products. Quality and reliability, as well as the latest technology from such a leading manufacturer as Illumina Inc., have now become even closer and more accessible to our…
Читать далее

IMG company has participated in the conference UARM

On the 25-27th of May 2017 IMG company participated in the International Symposium "Theory and Practice of Human Reproduction", which holds Ukrainian Association of Reproductive Medicine. Main area and the theme of the participation of the company IMG was "The non-invasive fetal tests in reproductive medicine by the new generation sequencing". We also presented the company…
Читать далее